Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01407068 · ClinicalTrials.gov registry record · Phase 3
Administration of Two Injections for Multiple Dupuytren's Contractures
A Phase 3 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT01407068: Completed Phase 3 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
NCT01407068 is a Phase 3 study that has completed, run by Endo USA Inc., a Keenova Therapeutics Company. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01407068, a Phase 3 study, has completed, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
The objectives of this study are to assess the safety and efficacy of concurrent administration of two injections of AA4500 into the same hand of subjects with multiple Dupuytren's contractures caused by palpable cords.
Interventions
- BIOLOGICAL AA4500 collagenase clostridium histolyticum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01407068
The ClinicalTrials.gov registry entry for NCT01407068 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endo USA Inc., a Keenova Therapeutics Company, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AA4500 collagenase clostridium histolyticum is the first listed.
NCT01407068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01407068 about?
NCT01407068 is a clinical study titled "Administration of Two Injections for Multiple Dupuytren's Contractures". The objectives of this study are to assess the safety and efficacy of concurrent administration of two injections of AA4500 into the same hand of subjects with multiple Dupuytren's contractures caused by palpable cords.
What is the current status of trial NCT01407068?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2011-09. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01407068?
The interventions under investigation include: AA4500 collagenase clostridium histolyticum (BIOLOGICAL).
Who is sponsoring clinical trial NCT01407068?
This trial is sponsored by Endo USA Inc., a Keenova Therapeutics Company, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.